Vulvar intraepithelial neoplasia: A current problem;Neoplasia intraepitelial vulvar: Um problema atual

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 8, 2008, Pages 420-426

  Fonseca Moutinho, José Alberto ^a,b,c  

^a Centro Médico Serpa Pinto   (Portugal)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^c Centro Hospitalar da Cova da Beira   (Portugal)

Author keywords

Genital neoplasms, female; Vulvar neoplasms diagnosis; Vulvar neoplasms therapy

Indexed keywords

ARTICLE; CARCINOMA IN SITU; FEMALE; HUMAN; VULVA TUMOR;

CARCINOMA IN SITU; FEMALE; HUMANS; VULVAR NEOPLASMS;

EID: 54949116573     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032008000800008     Document Type: Article

References (50)

1. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol. 2001;20(1):16-30.
2. Preti M, Mezzetti M, Robertson C, Sideri M. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an European Collaborative Study. BJOG. 2000;107(5):594-9.
3. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005;50(11):807-10.
4. Hørding U, Junge J, Poulsen H, Lundvall F. Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential. Gynecol Oncol. 1995;56(2):276-9.
5. Ueda Y, Enomoto T, Miyatake T, Shroyer KR, Yoshizaki T, Kanao H, et al. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa. Am J Clin Pathol. 2004;122(2):266-74.
6. Bonvicini F, Venturoli S, Ambretti S, Paterini P, Santini D, Ceccarelli C, et al. Presence and type of oncogenic papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. J Med Virol. 2005;77(1):102-6.
7. Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol. 2006;30(12):1513-8.
8. Rodolakis A, Diakomanolis E, Vlachos G, Iconomou T, Protopappas A, Stefanidis C, et al. Vulvar intraepithelial neoplasia (VIN) - diagnostic and therapeutic challenges. Eur J Gynaecol Oncol. 2003;24(3-4):317-22.
9. Vilmer C, Cavelier-Balloy B, Nogues C, Trassard M, Le Doussal V. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol. 1998;19(1):25-31.
10. Mene A, Buckley CH. Involvement of the vulval skin appendages by intraepithelial neoplasia. Br J Obstet Gynaecol. 1985;92(6):634-8.
11. Benedet JL, Wilson PS, Matisic J. Epidermal thickness and skin appendage involvement in vulvar intraepithelial neoplasia. J Reprod Med. 1991;36(8):608-12.
12. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 1992;166(5):1482-5.
13. Joura EA, Lösch A, Haider-Angeler, MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med. 2000;45(8):613-5.
14. Sykes P, Smith N, McCormick P, Frizelle FA. High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. Aust N Z J Obstet Gynaecol. 2002;42(1):69-74.
15. Sherman KJ, Daling JR, Chu J, Weiss NS, Ashley RL, Corey L. Genital warts, other sexually transmitted diseases, and vulvar cancer. Epidemiology. 1991;2(4):257-62.
16. Brinton LA, Nasca PC, Mallin K, Baptiste MS, Wilbanks GD, Richart RM. Case-control study of cancer of the vulva. Obstet Gynecol. 1990;75(5):859-66.
17. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst. 1997;89(20):1516-23.
18. Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol. 1997;90(5):748-54.
19. Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004;190(5):1241-8.
20. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A, HIV Epidemiology Research Study Group. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol. 2006;107(5):1023-8.
21. Barton SE, Maddox PH, Jenkins D, Edwards R, Cuzick J, Singer A. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet. 1988;2(8612):652-4.
22. Akerman G, Dussour C, Haddad B, Paniel BJ, Rouzier R. [Epidemiology of vulvar intra-epithelial neoplasias]. Gynecol Obstet Fertil. 2007;35(12):1251-6. French.
23. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol. 2006;30(3):310-8.
24. Husseinzadeh N, Recinto C. Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN 3). Gynecol Oncol. 1999;73(1):119-20.
25. Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol. 1994;84(5):741-5.
26. Bourgault Villada I, Moyal Barracco M, Ziol M, Chaboissier A, Barget N, Berville S, et al. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(+) and CD8(+) T-cell responses. Cancer Res. 2004;64(23):8761-6.
27. Mitchell A, Newton JM, Brite K, Einspahr J, Ellis M, Davis J, et al. Cyclooxigenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer. J Low Genit Tract Dis. 2007;11(2):80-5.
28. Riethdorf S, Neffen EF, Cviko A, Löning T, Crum CP, Riethdorf L. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol. 2004;35(12):1477-83.
29. Hantschmann P, Sterzer S, Jeschke U, Friese K. P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Anticancer Res. 2005;25(3A):1739-45.
30. McNally OM, Mulvany NJ, Pagano R, Quinn MA, Rome RM. VIN 3: a clinicopathologic review. Int J Gynecol Cancer. 2002;12(5):490-5.
31. Bernstein SG, Kovacs BR, Townsend DE, Morrow CP. Vulvar carcinoma in situ. Obstet Gynecol. 1983;61(3):304-7.
32. Shafi MI, Luesley DM, Byrne P, Samra JS, Redman CW, Jordan JA, et al. Vulval intraepithelial neoplasia--management and outcome. Br J Obstet Gynaecol. 1989;96(11):1339-44.
33. Kagie MJ, Kenter GG, Hermans J, Trimbos JB, Fleuren GJ. The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva. Int J Gynecol Cancer. 1997;7(1):50-7.
34. Bae-Jump VL, Bauer M, Van Le L. Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias. J Low Genit Tract Dis. 2007;11(1):8-11.
35. August CZ, Ganji M, Froula E. Misdiagnosis of high-grade vulvar intraepithelial neoplasia (VIN III) as mild cervical intraepithelial (CIN I) on Papanicolaou tests. Arch Pathol Lab Med. 2003;127(1):68-70.
36. Kagie MJ, Kenter GG, Fleuren, GJ, Trimbos JB. Vulvoscopy in benign and premalignant vulvar lesions: results of seven years vulvoscopy clinic. J Gynecol Tech. 1997;3(1):21-6.
37. Clinical stains for cancer. Lancet. 1982;1(8267):320-1.
38. Leroy JL, Vinatier D, Collier F, Thomas P. [Diagnosis of vulvar intraepithelial neoplasias (VIN)]. Gynecol Obstet Fertil. 2008;36(2):190-9. French.
39. Collins CG, Roman-Lopez JJ, Lee FY. Intraepithelial carcinoma of the vulva. Am J Obstet Gynecol. 1970;108(8):1187-91.
40. Boutselis JG. Intraepithelial carcinoma of the vulva. Am J Obstet Gynecol. 1972;113(6):733-8.
41. Buscema J, Woodruff JD, Parmley TH, Genadry R. Carcinoma in situ of the vulva. Obstet Gynecol. 1980;55(2):225-30.
42. Rutledge F, Sinclair M. Treatment of intraepithelial carcinoma of the vulva by skin excision and graft. Am J Obstet Gynecol. 1968;102(6):807-18.
43. Retteinmaier MA, Berman ML, DiSaia, PJ. Skinning vulvectomy for the treatment of multifocal vulvar intraepithelial neoplasia. Obstet Gynecol. 1987;69(2):247-50.
44. Di Saia PJ, Rich WM. Surgical approach to multifocal carcinoma in situ of the vulva. Am J Obstet Gynecol. 1981;140(2):136-45.
45. Wolcott HD, Gallup DG. Wide local excision in the treatment of vulvar carcinoma in-situ: a reappraisal. Am J Obstet Gynecol. 1984;150(6):695-8.
46. Ahr A, Rody A, Kissler S, Kaufmann M, Gätje R. [Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)]. Zentralbl Gynakol. 2006;128(6):347-51. German.
47. Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100(2):271-5.
48. Brown JV 3rd, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP. Laser ablation of surgical margins after excisional partial vulvectomy for VIN: Effect on recurrence. J Reprod Med. 2005;50(5):345-50.
49. van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008;358(14):1465-73.
50. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomized clinical trials. Lancet. 2007;369(9574):1693-702.